- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02749461
Validation of the Bernese Pain Scale for Neonates (BERN-PAIN)
Validation of the Bernese Pain Scale for Neonates With Consideration for Contextual Factors
Study Overview
Detailed Description
Preterm birth rates are rising worldwide, including in Europe. In 2014, Switzerland's rate of premature births reached 7.2%. Still, while significant progress in neonatal care has increased the long-term survival of preterm infants, other long-term outcomes remain problematic. As a result, affected infants commonly undergo exceedingly high numbers of painful procedures on a daily basis. For many, these treatment interventions take place at a crucial period in the development of the nociceptive and central nervous systems, i.e., at a developmental stage when repeated painful stimulus may induce both structural and functional reorganization of the nervous system and an altered pain response.
As infants are unable to communicate verbally, clinical pain assessment in neonates, particularly those delivered preterm, is highly challenging. Therefore, pain responses have to be observed according to physiological and behavioral indicators which might vary across preterm infants depending on their physiological and neurological development stages.
The Bernese Pain Scale for Neonates (BPSN) is a multidimensional pain assessment tool which is already widely used in clinical settings in the German speaking areas of Europe. Recent findings suggest that pain reaction is influenced by more than noxious stimulation alone: it is assumed that contextual factors, e.g., gestational age (GA) or gender, might also impact pain reactivity.
The aims of this validation study are:
- to undertake the psychometric testing of the BPSN regarding its concurrent validity with the Premature Infant Pain Profile-Revised (PIPP-R), construct validity, interrater and intrarater reliability, specificity and sensitivity;
- to examine the variability of pain reactions related to behavioural and physiological patterns across time;
- to assess the influence of contextual factors on the variability of pain reactions across GA groups; and
- to examine the relationship between behavioural and physiological indicators across time.
This multisite psychometric measurement study of the BPSN will use repeated measures design. The study will take place in three tertiary care hospitals (Bern, Zurich and Basel) in Switzerland. To examine the impact of GA on pain reaction and its variability, the infants will be stratified into six GA groups ranging from 24 0/7 to 42 0/7. Among preterm infants with GAs up to 36 6/7 weeks, five consecutive heel sticks within the first 14 days of life will be documented. Among healthy-term infants two heel sticks within the first days after birth will be documented. For each heel stick, measurements will be recorded for each of three phases: baseline, heel stick, and recovery. All phases will be videotaped and the child's pain reaction later rated according to the BPSN by five independent raters blinded to the measurement phase. Individual contextual factors of interest for this study are documented in a standardised way in all three participating Neonatal Intensive Care Units (NICUs), and can be extracted from patient charts.
This diagnostic study is intended to validate the BPSN with consideration for contextual factors influencing neonatal pain responses. Understanding and embedding the influences of contextual factors into a final version of the BPSN-Context will help clinicians more accurately assess pain in the clinical setting, and will eventually help them minimize the pain endured by neonates, particularly preterm neonates in NICUs. For preterm infants requiring intensive care, adequate and efficient pain management is an important factor in later motor and cognitive development. The investigators hope this study will contribute to the prevention of negative long-term outcomes in this patient population.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Toronto, Canada
- Lawrence S. Bloomberg Faculty of Nursing and Faculties of Medicine and Dentistry, University of Toronto
-
-
-
-
-
Basel, Switzerland
- Department of Neonatology, University Children's Hospital of Basel (UKBB)
-
Bern, Switzerland
- Neonatology, Children's Hospital, University Hospital of Bern
-
Zurich, Switzerland
- Neonatology, University Hospital of Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Preterm infants born between 24 0/7 and 36 6/7 weeks of gestation will be included if they are expected to undergo 5 routine heel capillary blood samples during the first 14 days of life; if they are ventilated or not ventilated; and if their parents give informed consent.
- Term infants born between 37 0/7 and 42 0/7 weeks of gestation will be included if they are expected to have at least 2 routine heel capillary blood samples during the first days of life and if their parents give informed consent.
Exclusion Criteria:
- Grade III oder IV intraventricular haemorrhaging
- Severe life-threatening malformation or suffer from any condition involving partial or total loss of sensitivity
- pHa < 7.15 (umbilical cord)
- Surgery for any reason
- Congenital malformation affecting brain circulation and cardiovascular system
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain response across time
Time Frame: 2-5 timepoints within the first 14 days of life
|
Change and variability of pain response across different time points will be measured with the BPSN
|
2-5 timepoints within the first 14 days of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Influence of individual contextual factors on pain response across time
Time Frame: 2-5 within the first 14 days of life
|
Time points of contextual factors documentation are determined by the clinical need for routine heel stick procedures within the first 14 days of life.
These time points are not fixed before hand but are based on ongoing clinical judgement during the first 14 days of life.
For each clinically determined time point for a heel stick appropriate contextual factors being relevant the day of the determined heel stick date will be extracted from patient chart.
|
2-5 within the first 14 days of life
|
Psychometric testing of the BPSN
Time Frame: 2-5 timepoints within the first 14 days of life
|
Psychometric testing will be done across all the five time points for baseline, heel stick and recovery phases
|
2-5 timepoints within the first 14 days of life
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Eva Cignacco, Prof. Dr., Bern University of Applied Sciences
Publications and helpful links
General Publications
- Schenk K, Stoffel L, Burgin R, Stevens B, Bassler D, Schulzke S, Nelle M, Cignacco E. The influence of gestational age in the psychometric testing of the Bernese Pain Scale for Neonates. BMC Pediatr. 2019 Jan 15;19(1):20. doi: 10.1186/s12887-018-1380-8.
- Cignacco E, Schenk K, Stevens B, Stoffel L, Bassler D, Schulzke S, Nelle M. Individual contextual factors in the validation of the Bernese pain scale for neonates: protocol for a prospective observational study. BMC Pediatr. 2017 Jul 19;17(1):171. doi: 10.1186/s12887-017-0914-9.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SNF 320030_159573
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Assessment
-
NYU Langone HealthTerminatedPain Measurement | Assessment, PainUnited States
-
Zonguldak Bulent Ecevit UniversityCompleted
-
Minia UniversityCompleted
-
Peking University People's HospitalCompleted
-
Lund UniversityGöteborg University; Jonkoping UniversityRecruitingPain | Child, Only | Assessment, SelfSweden
-
Universidad de GranadaUnknownNeck Pain | Assessment, Self | Kinesiophobia
-
British University In EgyptCompleted
-
HATİCE ÇETİNCompletedPain | Low Back Pain | Disability Physical | Assessment, SelfTurkey
-
Peking University People's HospitalChinese PLA General Hospital; Zhejiang University; First Affiliated Hospital...UnknownPostoperative Pain | Elderly | Model | Pain AssessmentChina
-
HATİCE ÇETİNCompletedPain | Neck Pain | Evaluations, Diagnostic Self | Assessment, SelfTurkey
Clinical Trials on heel stick
-
University of ArizonaNot yet recruiting
-
The University of Texas Health Science Center,...Memorial Hermann HospitalCompleted
-
Isparta University of Applied SciencesCompleted
-
Rocky Mountain University of Health ProfessionsPerformance Dynamics; Indiana Athletic Trainers' AssociationCompletedFunctional PerformanceUnited States
-
Isparta University of Applied SciencesAkdeniz UniversityCompleted
-
Kamineni Academy of Medical Sciences and Research...CompletedMicrobial Colonization
-
Philip Morris Products S.A.CompletedSmoking, TobaccoUnited Kingdom
-
Alyn Pediatric & Adolescent Rehabilitation HospitalCompletedHeart Rate | Gait Velocity | Step Time and Length | Symmetry | Step Time and Length VariabilityIsrael
-
Nantes University HospitalCompleted